622
Views
9
CrossRef citations to date
0
Altmetric
Clinical Immunology

Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria

, , , , , , , , , & show all
Pages 35-39 | Received 20 Sep 2017, Accepted 19 Oct 2017, Published online: 10 Nov 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.